Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol. 1976

R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten

1. The anti-hypertensive effect of atenolol was greater than that of bendrofluazide. 2. The change in systolic blood pressure caused by bendrofluazide showed a significant inverse correlation iwth the plasma renin concentration (r=-0-47; P less than 0-01). 3. The correlation between the change in systolic blood pressure caused by atenolol and the plasma renin concentration was not significant (r =0-28; 0-1 greater than P greater than 0-05). 4. Plasma renin concentration was unaffected by atenolol.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082
D001539 Bendroflumethiazide A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810) Bendrofluazide,Aprinox,Benzide,Benzide-M,Berkozide,Centyl,Esberizid,Naturetin,Naturine,Neo-NaClex,Pluryl,Urizid,Benzide M,Neo NaClex

Related Publications

R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
January 1977, Postgraduate medical journal,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
October 1975, British medical journal,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
July 2010, The Journal of clinical endocrinology and metabolism,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
September 1984, Japanese circulation journal,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
January 1979, Kardiologia polska,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
July 1998, Journal of human hypertension,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
January 1970, Naunyn-Schmiedebergs Archiv fur Pharmakologie,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
August 1971, Klinische Wochenschrift,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
September 1974, Zeitschrift fur klinische Chemie und klinische Biochemie,
R Fagard, and A Amery, and J F Deplaen, and P Lijnen, and A Missotten
May 1980, Research communications in chemical pathology and pharmacology,
Copied contents to your clipboard!